| P2093 | author name string | David Cohen | |
| | Jean-Jacques Breton | |
| | Jean-Marc Guile | |
| | Réal Labelle | |
| | Johanne Renaud | |
| | Leon Tourian | |
| | Martin Gignac | |
| | Amélie LeBoeuf | |
| P2860 | cites work | Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance | Q48863773 |
| | The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction | Q48973325 |
| | Who are the children with severe mood dysregulation, a.k.a. "rages"? | Q50892885 |
| | Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. | Q50960243 |
| | Temper tantrums in young children: 2. Tantrum duration and temporal organization. | Q51023410 |
| | Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation. | Q51900932 |
| | Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. | Q51911176 |
| | Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded. | Q52067679 |
| | Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7 years. | Q52085319 |
| | Use of propranolol to decrease aggressive outbursts in younger patients. Open study reveals potentially favorable outcome. | Q54136039 |
| | Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children | Q67982562 |
| | Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study | Q71781056 |
| | Lithium treatment of conduct disorders in adolescents | Q73196313 |
| | Resolved: mania is mistaken for ADHD in prepubertal children | Q77454940 |
| | Family and parenting interventions for conduct disorder and delinquency: a meta-analysis of randomized controlled trials | Q78563253 |
| | Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder | Q95801819 |
| | Pharmacotherapy of aggression in children and adolescents: efficacy and effect size | Q24648097 |
| | National trends in the outpatient diagnosis and treatment of bipolar disorder in youth | Q28244462 |
| | Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004 | Q28288705 |
| | Clonidine treatment of hyperactive and impulsive children with autistic disorder | Q28318016 |
| | Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design | Q33180244 |
| | Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation | Q33411020 |
| | Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders | Q33757565 |
| | Rages--what are they and who has them? | Q33799273 |
| | Helping Children Hospitalized for Rages | Q34111063 |
| | Rages or temper tantrums? The behavioral organization, temporal characteristics, and clinical significance of angry-agitated outbursts in child psychiatry inpatients | Q34139506 |
| | Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder | Q34325927 |
| | Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder | Q34346051 |
| | Pediatric bipolar disorder versus severe mood dysregulation: risk for manic episodes on follow-up | Q34398129 |
| | Defining clinical phenotypes of juvenile mania | Q35075420 |
| | Lithium in hospitalized children at 4 and 8 weeks: mood, behavior and cognitive effects | Q36004604 |
| | The Affective Reactivity Index: a concise irritability scale for clinical and research settings | Q36358602 |
| | The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation | Q37186841 |
| | A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder | Q38436733 |
| | Psychopharmacology of temper outbursts. A review. | Q39739546 |
| | Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder | Q42249064 |
| | Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study | Q42279171 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. | Q43292973 |
| | A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder | Q43504977 |
| | A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder | Q43657283 |
| | Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial | Q43671991 |
| | Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. | Q45023301 |
| | The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children | Q45038759 |
| | Evaluation and treatment of rage in children and adolescents | Q46172572 |
| | Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study | Q46486037 |
| | Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation | Q46611011 |
| | A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders | Q46725719 |
| | Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up | Q46727052 |
| | Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial | Q46850329 |
| | An open-label trial of risperidone in children and adolescents with severe mood dysregulation | Q48853768 |
| P433 | issue | 1 | |
| P921 | main subject | Disruptive mood dysregulation disorder | Q18459180 |
| P304 | page(s) | 41-54 | |
| P577 | publication date | 2015-03-04 | |
| P1433 | published in | Journal of the Canadian Academy of Child and Adolescent Psychiatry | Q26841954 |
| P1476 | title | Treatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation Disorder | |
| P478 | volume | 24 | |